Cargando…
Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial
IMPORTANCE: Observational studies have suggested that angiotensin receptor blockers are associated with a unique cognitive protection. It is unclear if this is due to reduced blood pressure (BP) or angiotensin receptors type 1 blockade. OBJECTIVE: To determine neurocognitive effects of candesartan v...
Autores principales: | Hajjar, Ihab, Okafor, Maureen, McDaniel, Darius, Obideen, Malik, Dee, Elizabeth, Shokouhi, Mahsa, Quyyumi, Arshed A., Levey, Allan, Goldstein, Felicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411539/ https://www.ncbi.nlm.nih.gov/pubmed/32761160 http://dx.doi.org/10.1001/jamanetworkopen.2020.12252 |
Ejemplares similares
-
Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
por: Hajjar, Ihab, et al.
Publicado: (2022) -
Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials
por: Henley, Brandon, et al.
Publicado: (2023) -
Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019) -
Neurobiological Pathways Linking Acute Mental Stress to Impairments in Executive Function in Individuals with Coronary Artery Disease
por: Moazzami, Kasra, et al.
Publicado: (2021) -
UTILITY OF EXECUTIVE FUNCTION TO IDENTIFY EARLY COGNITIVE IMPAIRMENT IN AFRICAN AMERICANS
por: Garrett, Stephanie, et al.
Publicado: (2019)